Pancreatic Cancer Archives - Page 48 of 48

Metformin use was associated with improved outcome of patients with diabetes and pancreatic cancer, according to a study published in Clinical Cancer Research online.

Endocrine Cancer

Percutaneous Irreversible Electroporation Ablates Pancreatic Tumors

By

Debra Hughes, MS

March 30, 2012

Percutaneous irreversible electroporation (IRE) is feasible and safe in patients with locally advanced pancreatic adenocarcinoma, with 2 of 8 patients with unresectable disease achieving a margin-negative resection.

Endocrine Cancer

Drug Ups Effect of Gemcitabine in Pancreatic Cancer

February 29, 2012

The efficacy of gemcitabine in treating pancreatic cancer can be greatly improved by a second drug that increases gemcitabine levels by preventing its breakdown, according to a study published online February 28 in Cancer Discovery.

Endocrine Cancer

Dual VEGF and c-MET Inhibition Synergistically Reduces Tumor Invasion and Metastasis

By

Debra Hughes, MS

February 24, 2012

Simultaneous inhibition of c-Met and VEGF signaling slowed tumor growth and reduced invasion and metastasis in a pancreatic neuroendocrine mouse model, results of a study published online in Cancer Discovery February 24 have found.

General Oncology

Lynch Syndrome Linked to Increased Risk of Many Cancers

February 14, 2012

Increased risk of breast, pancreatic cancers and other cancers with Lynch syndrome; relatives without mutations have no increased risk

Uncategorized

Gene Involved in Familial Pancreatic Cancer Identified

January 4, 2012

Specific ataxia telangiectasia mutated (ATM) gene mutations that increase the hereditary risk of familial pancreatic ductal adenocarcinoma have been identified.